Top news of the week: 11.03.2021.
Companies And Industries
Ex-Intercept CMO Campagna lands at immune regulation biotech Q32
Jason Campagna has taken up the chief medical officer position (CMO) at Q32 Bio. Campagna arrives at Q32 after a stint at Intercept Pharmaceuticals that saw him rise to the CMO role at the ...
Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data
Merck has had a torrid time with COVID-19 vaccines and a major setback with its OncoImmune-partnered pandemic med, but now, finally, it’s seeing some good news on that R&D front.
Report: 2021 Could Represent a Major Shift in Central Nervous System Therapeutics
One of the key drivers of a shift in CNS drugs hinges on the success or failure of Biogen’s aducanumab for Alzheimer’s disease.
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections
The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
CytoDyn digs deep for signs of efficacy in COVID-19 trial flop
A phase 3 clinical trial of CytoDyn’s leronlimab in COVID-19 patients has missed its primary and all major secondary endpoints. However, CytoDyn zeroed in on a subgroup of patients and ...
2021 Biopharma Update on the Novel Coronavirus: March 9
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 9, 2021.
GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits
GlaxoSmithKline managed to notch some wins during the pandemic-challenged year of 2020, but COVID-19 took its toll—not only on the British pharma's finances, but on CEO Emma Walmsley’s pay, ...
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.